NCJ Number
118769
Date Published
1987
Length
11 pages
Annotation
These guidelines are intended for use by States in developing or enhancing programs to control the diversion of legal drugs into the illicit drug market.
Abstract
The abuse of these controlled substances accounted for 54 percent of the Drug Abuse Warning Network mentions in 1985. These diverted drugs become available to drug abusers as a result of illegal activity by registrants, abuse and fraud related to prescriptions, indiscriminate prescribing, and theft. The Pharmaceutical Diversion Program aims to strengthen the role of law enforcement, professional licensing boards, and regulatory agencies in reducing the diversion of legitimately produced drugs. It focuses on data collection and analysis, investigations and professional license discipline, improved regulatory controls, detection of illegal prescriptions, training to improve diversion control, and improved communication. Forms, addresses of Drug Enforcement Administration staff in each State, and list of 4 reports from the United States General Accounting Office are included.